The effect of methamphetamine on the release of acetylcholine in the rat striatum

European Journal of Pharmacology

Volumn 360, Issue 2-3, 1998, Pages 131-137

  Taguchi, Kyoji ^a   Atobe, Jun ^a   Kato, Masatoshi ^a   Chuma, Toichiro ^a   Chikuma, Toshiyuki ^a   Shigenaga, Toshiro ^a   Miyatake, Tadashi ^a  

^a Showa Pharmaceutical University   (Japan)

Author keywords

Acetylcholine; Dopaminergic system; Methamphetamine; Microdialysis, in vitro; Microdialysis, in vivo; Striatum

Indexed keywords

ACETYLCHOLINE; HALOPERIDOL; METHAMPHETAMINE; METIROSINE; NEOSTIGMINE; OXIDOPAMINE; RESERPINE; SODIUM CHANNEL; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG INFUSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ACETYLCHOLINE; ADRENERGIC AGENTS; ADRENERGIC UPTAKE INHIBITORS; ALPHA-METHYLTYROSINE; ANIMALS; APOMORPHINE; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; ENZYME INHIBITORS; MALE; METHAMPHETAMINE; MICRODIALYSIS; OXIDOPAMINE; RATS; RATS, WISTAR; RESERPINE; TETRODOTOXIN;

EID: 0032491605     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00653-0     Document Type: Article

References (34)

1. Acquas E., Fibiger H.C. Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition. J. Neurochem. 70:1998;1088-1093.
2. Acquas E., Wilson C., Fibiger H.C. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo. J. Pharmacol. Exp. Ther. 281:1997;360-368.
3. Ajima A., Yamaguchi T., Kato T. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions. Brain Res. 518:1990;193-198.
4. 3H ]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between β-phenylethylamine and amphetamine J. Pharmacol. Exp. Ther. 235:1985;220-229.
5. Butcher S.P., Fairbrother I.S., Kelly J.S., Arbuthnott G.W. Amphetamine-induced dopamine release in the rat striatum: in vivo microdialysis study. J. Neurochem. 50:1988;346-355.
6. Cadoni C., Pinna A., Russi G., Consolo S., Chiara D.I. Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and fos immunohistochemistry. Neuroscience. 65:1995;1027-1039.
7. 3H -acetylcholine from slices of the rat striatum: involvement of dopaminergic receptors Eur. J. Pharmacol. 87:1983;167-168.
8. Consolo S., Wu C.F., Fusi R. D1-receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum. J. Pharmacol. Exp. Ther. 242:1987;300-305.
9. Damsma G., DeBoer P., Westerink B.H.C., Fibiger H.C. Dopaminergic regulation of striatal cholinergic interneurons: an in vivo microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;523-527.
10. Damsma G., Robertson G.S., Tham C.S., Fibiger H.C. Dopaminergic regulation of striatal release: importance of D1 and N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 259:1991;1064-1072.
11. Day J., Damsma G., Fibiger H. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol. Biochem. Behav. 38:1991;723-729.
12. DeBelleroche J., Coutinho-Netto J., Bradford H.F. Dopamine inhibition of the release of endogenous acetylcholine from corpus striatum and cerebral cortex in tissue slices and synaptosomes: a presynaptic response? J. Neurochem. 39:1982;217-222.
13. DeBoer P., Abercrombie E.D. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtype. J. Pharmacol. Exp. Ther. 277:1996;775-783.
14. DeBoer P., Damsma G., Fibiger H.C., Timmerman W., DeVries J.B., Westerink B.H.C. Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;528-534.
15. DeBoer P., Damsma G., Schram Q., Stoof J.C., Zaagsma J., Westerink B.H.C. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;144-152.
16. Florin S.M., Kuczenki R., Segal D.S. Amphetamine-induced changes in behavior and caudate extracellular acetylcholine. Brain Res. 581:1992;53-58.
17. Guix T., Hurd Y.H., Ungerstedt U. Amphetamine enhances extracellular concentration of dopamine and acetylcholine in dorsolateral striatum and nucleus accumbens of freely moving rats. Neurosci. Lett. 138:1992;137-140.
18. Hagiwara Y., Taguchi K., Atobe J., Suzuki Y., Kubo T. An investigation into the effects of apomorphine on the release of acetylcholine in the striatum of freely-moving rat using in vivo microdialysis. Gen. Pharmacol. 24:1993;1373-1377.
19. Imperato A., Obinu M.C., Gessa G. Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur. J. Pharmacol. 238:1993;377-381.
20. Kitai S.T., Kocsis J.D., Preston R.J., Sugimori M. Monosynaptic inputs to caudate neurons identified by intracellular injection of horseradish peroxidase. Brain Res. 109:1976;601-609.
21. Mandel R.J., Leanza G., Nilsson O.G., Rosengren E. Amphetamine induces excess release of striatal acetylcholine in vivo that is independent of nigrostriatal dopamine. Brain Res. 653:1994;57-65.
22. O'Dell S.J., Weihmuller F.B., Marshall J.F. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. J. Neurochem. 60:1993;1792-1799.
23. Ögren S.O., Hall H., Köhler C., Magnusson O., Sjöstrand S.E. The selective dopamine D2-receptor antagonist raclopride discriminates between dopamine mediated motor functions. Psychopharmacology. 90:1986;287-294.
24. Okada M. Effects of a new thyrotropin releasing hormone analogue, YM-14673, on the in vivo release of acetylcholine as measured by intracerebral dialysis in rats. J. Neurochem. 56:1991;1544-1547.
25. Parker E.M., Cubeddu L.X. Effects of D-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum: I. Release in the absence of vesicular transmitter stores. J. Pharmacol. Exp. Ther. 237:1986;179-192.
26. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, London.
27. Raiteri M., Cerrito F., Cervoni A.M., Levi G. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208:1979;195-202.
28. Scheel-Krüger J. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Eur. J. Pharmacol. 14:1971;47-59.
29. Sharp T., Zetterström T., Ljungberg T., Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:1987;322-330.
30. Taguchi K., Hagiwara Y., Suzuki Y., Kubo T. Effects of morphine on release of acetylcholine in the rat striatum: an in vivo microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;9-13.
31. Ungerstedt, U., 1984. Measurement of neurotransmitter release by intracranial dialysis. In: Marsden, C. (Ed.), Measurement of Neurotransmitter Release In Vivo. Wiley, New York, pp. 81-105.
32. Yamanaka Y., Yamamoto T., Egashira T. Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice. Jpn. J. Pharmacol. 33:1983;33-40.
33. Zetterström T., Sharp T., Marsden C.A., Ungerstedt U. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after D-amphetamine. J. Neurochem. 41:1983;769-1773.
34. Zocchi A., Pert A. Increases in striatal acetylcholine by SKF-38393 are mediated through D1 dopamine receptors in striatum and not in the frontal cortex. Brain Res. 627:1993;186-192.